Recursion Pharmaceuticals (RXRX) Q4 2023 Earnings

Feb 27Confirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-0.45
-0.42
-0.38
-0.35

Details

Expected EPS
-0.44875
Actual EPS
-0.42
Surprise EPS
0.03
Surprise Percent
+6.41%

Description

⁨Recursion Pharmaceuticals⁩ (⁦RXRX⁩) has reported earnings of ⁦-0.42⁩ per share for ⁦Q4 2023⁩.

0 Comments

Share your thoughts